50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Health risks associated with the pharmaceuticals in wastewater

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The overwhelming population growth in recent decades and water crisis along with limited and uneven geographical distribution of fresh water resources is a growing challenge for the economic and human development. Wastewater reclamation and use could be an alternative for intact water sources and a promising solution to water scarcity and unequal distribution. However, wastewater is a double-edged resource both as an accessible water source for food production and human usage and concurrently may carry uncharacterized content with unknown toxicological profile causing acute or long-term health risks. Pharmaceuticals, cosmeceuticals, nanomaterials and their chemical decomposition derivatives found in wastewater are not well known in many cases. Their unknown toxicity, teratogenicity and carcinogenicity profile associated with lack of monitoring and control measures impose a significant hazard risk on the public health. This paper reviews the evidence on the health risks associated with the wastewater use for irrigated food production and the imposed risk on the end consumers mainly from pharmaceutical industry and related research facilities. Then, we suggest an applied framework for planning and policy-making to mitigate the health risks and optimally employ reclaimed wastewater for human purposes.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: not found
          • Article: not found

          Occurrence of drugs in German sewage treatment plants and rivers1Dedicated to Professor Dr. Klaus Haberer on the occasion of his 70th birthday.1

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            NANOMATERIALS IN THE ENVIRONMENT: BEHAVIOR, FATE, BIOAVAILABILITY, AND EFFECTS

            The recent advances in nanotechnology and the corresponding increase in the use of nanomaterials in products in every sector of society have resulted in uncertainties regarding environmental impacts. The objectives of this review are to introduce the key aspects pertaining to nanomaterials in the environment and to discuss what is known concerning their fate, behavior, disposition, and toxicity, with a particular focus on those that make up manufactured nanomaterials. This review critiques existing nanomaterial research in freshwater, marine, and soil environments. It illustrates the paucity of existing research and demonstrates the need for additional research. Environmental scientists are encouraged to base this research on existing studies on colloidal behavior and toxicology. The need for standard reference and testing materials as well as methodology for suspension preparation and testing is also discussed.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Global life cycle releases of engineered nanomaterials

                Bookmark

                Author and article information

                Contributors
                00982164122319 , Mohammad@TUMS.Ac.Ir , Mohammad.Abdollahi@UToronto.Ca
                Journal
                Daru
                Daru
                DARU Journal of Pharmaceutical Sciences
                BioMed Central (London )
                1560-8115
                2008-2231
                12 April 2017
                12 April 2017
                2017
                : 25
                : 9
                Affiliations
                [1 ]GRID grid.411705.6, Department of Toxicology and Pharmacology, Faculty of Pharmacy, , Tehran University of Medical Sciences, ; Tehran, Iran
                [2 ]GRID grid.411705.6, Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, , Tehran University of Medical Sciences, ; Tehran, Iran
                Article
                176
                10.1186/s40199-017-0176-y
                5389172
                28403898
                80d5ea93-c43b-4cb9-8a01-f73e1ac930c2
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 24 November 2016
                : 6 April 2017
                Categories
                Editorial
                Custom metadata
                © The Author(s) 2017

                Pharmacology & Pharmaceutical medicine
                wastewater,chemical and pharmaceutical residues,toxicity,regulatory framework,public health risk

                Comments

                Comment on this article